In the high-fat diet-induced sarcopenic obesity model, the intervention of semaglutide showed significant anti-inflammatory effects
GLP-1 weight loss injections are considered safe for most individuals when used under the supervision of a healthcare provider
Some patients may experience symptoms such as nausea, vomiting, diarrhea, and constipation
Injectables built the category, but pills can expand it
In summary, we hypothesized that hunger-free fasting could be beneficial for long-term weight management for contributing to appetite control
The FDA noted that it had received over 1000 reports of adverse events arising from compounded GLP-1 dosing errors and unapproved ingredients and suggested that such adverse events are likely underreported due to the limited application of federal regulations to state-licensed pharmacies